- Summary: How HIV damages the immune system
- The pathway to disease
- The virus and the immune system
- Exposure and primary infection
- Strains of HIV
- Mechanisms of CD4 T-cell destruction
- Immune responses to HIV
- Immune disruption
- Why do CD4 T-cells disappear in HIV infection?
- Progression to clinical disease
Progression to clinical disease
In untreated people, the average loss of CD4 T-cells in blood is about 60 cells/mm3 per year but there is a wide range in this change among different people. Loss of CD4 T-cells and the direct and indirect abnormalities caused by this mainly affect acquired immunity and cell-mediated responses. Newly encountered antigens will not cause much of an immune response, and loss of memory T-cells will take away the increased efficiency in responding to antigens encountered more than once. This type of immune deficiency makes people more susceptible to disease from viruses, intracellular bacteria, fungi and some protozoa.
Humoral immunity (using B-cells) will not be so badly affected if memory cells for recognising common antigens exist. Most adults have a large population of B-cells which are good at responding to common bacteria that the body has seen before. Children do not have such good immune memory and in HIV infection children have problems with a wider range of bacteria than adults. Lack of proper cytokine release also affects the action of most immune cells including the phagocytic cells: macrophages and neutrophils.
In progressive immune deficiency a group of relatively minor conditions called AIDS-related complex (ARC) generally appears which can feature problems with weight loss, non-specific diarrhoea, oral fungal infection (Candida or thrush) and various skin conditions. AIDS is a more serious group of potentially life-threatening secondary infections and two types of cancers, both of which may be caused by viral infections. The manifestations of AIDS depend on the type of infection and which part of the body is affected. Many of these conditions respond to medical treatment. Some, such as Pneumocystis pneumonia, may resolve but can reappear later on.
latest aidsmap news
- Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis
- Wide variation found in anal HPV viral loads in HIV-positive men
- Offering rapid point-of-care tests would increase uptake of HIV testing
- Low rate of spontaneous hepatitis C clearance in patients with HIV; early HIV treatment recommended for those with chronic hepatitis C infection
- Cluster of multi-drug resistant HIV transmissions in Seattle
- Hypersensitivity testing for abacavir slightly more cost-effective than tenofovir use, if both drugs equally potent
- HIV no longer bar to granting of US visa for short visits
- Kidney disease risk increased for patients with HIV and hepatitis C
- Nearly one in three UK HIV patients has considered suicide in the previous week
- A new day for health in South Africa: Manto is replaced as health minister by TAC supporter
